Cobalt-57-bleomycin scanning of hila and mediastinum in patients with bronchial carcinoma: a prospective study.
Authors:
- J J RaskerJRJ J Rasker
- H BeekhuisHBH Beekhuis
- A M van de WalAWA M van de Wal
- J N Homan van der HeideJHJ N Homan van der Heide
- M G WoldringMWM G Woldring
Open Access
Abstract
An immunocytochemical unlabelled antibody method using rabbit antihuman lysozyme, antirabbit immunoglobulin, and soluble rabbit antihorseradish peroxidase/horseradish peroxidase complexes was used to study the fine structural distribution of lysozyme in human bronchial glands. None was identified in mucous cells but there was heavy staining of the serous cell granules. The serous cell granules were not stained uniformly, suggesting the presence of other secretory products but lysozyme secretion appears to be a major function of these cells. The pathological implications of this are discussed.Keywords
This publication has 5 references indexed in Scilit:
- Clinical Evaluation of Radio-Labelled Bleomycin for Tumor DetectionNuklearmedizin-Nuclear Medicine, 1978
- Labelling of Bleomycin with Cobalt-57, Indium-111, Technetium-99m, Mercury-197, Lead-203, and Copper-67Nuklearmedizin-Nuclear Medicine, 1976
- Some experience with 57Co-labeled bleomycin as a tumor-seeking agent.1975
- Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.1974
- Comparison of 133Xenon regional studies during spontaneous breathing and bronchospirometry.1974